Artwork

Content provided by VJOncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by VJOncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Highlights in bladder cancer at ASCO 2023: NORSE, RAGNAR, and THOR

8:20
 
Share
 

Manage episode 374904995 series 2424442
Content provided by VJOncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by VJOncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we will be covering highly anticipated updates in urothelial carcinoma presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023 in Chicago, IL. We are joined by Arlene Siefker-Radtke, MD of The University of Texas MD Anderson Cancer Center. Professor Siefker-Radtke is a leading expert in genitourinary cancer and will be sharing insights and updates from the ASCO 2023 Annual Congress, including a discussion of the NORSE (NCT03473743), THOR (NCT03390504), and RAGNAR (NCT04083976) trials. These trials investigated the use of the FGFR inhibitor, erdafitinib, in comparison or combination with other therapies.

The post Highlights in bladder cancer at ASCO 2023: NORSE, RAGNAR, and THOR appeared first on VJOncology.

  continue reading

177 episodes

Artwork
iconShare
 
Manage episode 374904995 series 2424442
Content provided by VJOncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by VJOncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we will be covering highly anticipated updates in urothelial carcinoma presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023 in Chicago, IL. We are joined by Arlene Siefker-Radtke, MD of The University of Texas MD Anderson Cancer Center. Professor Siefker-Radtke is a leading expert in genitourinary cancer and will be sharing insights and updates from the ASCO 2023 Annual Congress, including a discussion of the NORSE (NCT03473743), THOR (NCT03390504), and RAGNAR (NCT04083976) trials. These trials investigated the use of the FGFR inhibitor, erdafitinib, in comparison or combination with other therapies.

The post Highlights in bladder cancer at ASCO 2023: NORSE, RAGNAR, and THOR appeared first on VJOncology.

  continue reading

177 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide